Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Assessment of Safety and Pharmacokinetics of a Low Dose of Methotrexate in Healthy Adult Male Kenyan Volunteers

NCT00791531 is registered in ClinicalTrials.gov with KEMRI-Wellcome Trust Collaborative Research Program as lead sponsor.

NCT NCT00791531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00791531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Assessment of Safety and Pharmacokinetics of a Low Dose of Methotrexate in Healthy Adult Male Kenyan Volunteers
Lead sponsor
KEMRI-Wellcome Trust Collaborative Research Program
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2009
Completion date
August 31, 2009
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria